Ignite Creation Date:
2024-05-05 @ 6:34 PM
Last Modification Date:
2024-10-26 @ 9:34 AM
Study NCT ID:
NCT00500071
Status:
COMPLETED
Last Update Posted:
2022-03-10
First Post:
2007-07-10
Brief Title:
Dose-Optimization Study Evaluating the Efficacy Safety and Tolerability of Vyvanse Lisdexamfetamine Dimesylate in Children Aged 6-12 Diagnosed With ADHD
Sponsor:
Shire
Organization:
Takeda
Key Dates - Follows AllAPIJSON File Order
Start Date:
2007-06-28
Start Date Type:
ACTUAL
Primary Completion Date:
2008-01-02
Primary Completion Date Type:
ACTUAL
Completion Date:
2008-01-02
Completion Date Type:
ACTUAL
First Submit Date:
2007-07-10
First Submit QC Date:
July 10 2007
Study First Post Date:
2007-07-12
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
2009-09-01
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-02-25
Last Update Post Date:
2022-03-10
Last Update Post Date Type:
ACTUAL